Robert F. Kennedy Jr. revived a blame‑oriented tone in public health by linking personal choice to disease outcomes. His remarks about weight and drug use echo a bygone era, challenging modern destigmatization efforts.

Kennedy’s stance contrasts with the 2024 CDC push for person‑first language and the 2023 American Medical Association’s recognition of obesity as a disease. Critics argue that stigma can deter testing and treatment, while supporters claim it sharpens personal accountability.

Public health scholars note that stigma historically reduced smoking rates but also harmed vulnerable groups, as seen during the AIDS crisis. A balanced approach—termed “constructive responsibility”—seeks to hold systems accountable without abandoning individual choice. The debate underscores the tension between medical messaging and market interests in health‑tech and pharmaceutical sectors.